Clinical Trials Browser

Terminated × Prostatic Neoplasms × Clear all

NCT02478112 2026-03-17

BioPro-RCMI

Phase NA Terminated

Prostatic Neoplasms

NCT03360721 2026-03-16

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT03652298 2026-03-13

NeuroPrevPTSD

Phase 2 Terminated

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Prostatic Neoplasms, Stress Disorders, Post-Traumatic, Colorectal Neoplasms

NCT02946996 2026-03-05

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Phase 2 Terminated

41 enrolled 8 charts

Prostatic Neoplasms

NCT05676463 2026-03-03

MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT00999960 2026-02-25

PERLE

Phase NA Terminated

Neoplasms, Prostatic Neoplasms

NCT06047509 2026-02-25

Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for Guidance

Phase NA Terminated

Prostatic Neoplasms

NCT01885949 2026-02-24

Tivozanib + Enzalutamide in Adv Prostate Cancer

Phase 2 Terminated

5 enrolled 7 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT04876651 2026-02-20

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Phase 3 Terminated

Prostatic Neoplasms

NCT04754425 2026-02-06

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT02886546 2026-01-30

Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic Prostatectomy

Phase NA Terminated

Prostatic Neoplasms

NCT05366842 2026-01-30

Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care

Phase 2 Terminated

3 enrolled 5 charts

Erectile Dysfunction, Prostatic Neoplasms

NCT03553602 2026-01-29

BEACON

Phase 1/2 Terminated

3 enrolled 7 charts

Prostatic Neoplasms

NCT02125617 2026-01-14

uPARCRPC

Prostatic Neoplasms

NCT01995058 2026-01-08

Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC

Phase 2 Terminated

54 enrolled 11 charts

Prostatic Neoplasms

NCT05067777 2025-12-15

mPROSTATE

Phase 2 Terminated

Prostatic Neoplasms

NCT06347809 2025-12-15

DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine

Prostatic Neoplasms

NCT02772562 2025-12-12

Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy

Phase 2 Terminated

33 enrolled 7 charts

Prostatic Neoplasms

NCT04176497 2025-12-11

PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study

Phase 2 Terminated

8 enrolled 17 charts

Prostatic Neoplasms

NCT04635059 2025-11-17

BLAST

Phase 2 Terminated

6 enrolled 6 charts

Prostatic Neoplasms

NCT05037500 2025-11-12

Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms

NCT05617040 2025-11-10

Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer

Phase 1/2 Terminated

22 enrolled 11 charts

Prostatic Neoplasms

NCT02711137 2025-10-21

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Phase 1/2 Terminated

137 enrolled 31 charts

BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Primary Myelofibrosis

NCT03792841 2025-10-16

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Phase 1 Terminated

Bites and Stings, Prostatic Neoplasms

NCT04616547 2025-10-03

Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones

Phase 2 Terminated

1 enrolled 8 charts

Prostatic Neoplasms

NCT03503097 2025-10-01

GENTleMEN

Neoplasm Metastasis, Prostatic Neoplasms

NCT03284346 2025-09-29

Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors

Phase NA Terminated

BreastGenitourinaryOther

Breast Neoplasms, Obesity, Prostatic Neoplasms, Overweight, Sedentary Behavior

NCT06516510 2025-09-25

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

Phase EARLY_PHASE1 Terminated

Prostatic Neoplasms

NCT05733351 2025-09-15

Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms

NCT03843918 2025-09-10

A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer

Phase 1/2 Terminated

Prostatic Neoplasms

NCT05633160 2025-08-29

COMBAT

Phase 1/2 Terminated

Prostatic Neoplasms

NCT05605522 2025-08-24

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

Phase 1 Terminated

GastrointestinalGenitourinaryHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Prostatic Neoplasms, Sarcoma, Ewing, Stomach Neoplasms, Colorectal Neoplasms

NCT03485794 2025-08-12

Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

Prostatic Neoplasms

NCT05369000 2025-08-01

Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms

NCT04832997 2025-07-20

Micro-ultrasound for Prostate Cancer Diagnosis

Phase NA Terminated

Prostatic Neoplasms

NCT06655064 2025-07-14

Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

Adenocarcinoma, Prostatic Neoplasms

NCT05872503 2025-07-10

Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy

Prostatic Neoplasms

NCT03432897 2025-07-08

337

Phase 2 Terminated

1 enrolled 8 charts

Prostatic Neoplasms

NCT01231932 2025-06-19

Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors

BreastGenitourinary

Breast Neoplasms, Fatigue, Neoplasms, Prostatic Neoplasms

NCT05712174 2025-06-12

A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer

Phase 2 Terminated

Neoplasms, Prostatic Neoplasms

NCT03712371 2025-06-10

Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients

Phase 1/2 Terminated

12 enrolled 9 charts

Prostatic Neoplasms

NCT04261777 2025-06-03

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Phase 3 Terminated

Neoplasm Metastasis, Prostatic Neoplasms

NCT04927663 2025-05-20

11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression

Phase 1 Terminated

2 enrolled 5 charts

Prostatic Neoplasms

NCT00635167 2025-05-16

Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)

Phase NA Terminated

1 enrolled 3 charts

Prostatic Neoplasms

NCT04926181 2025-05-15

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Phase 2 Terminated

2 enrolled 12 charts

GenitourinaryThoracic

Prostatic Neoplasms, Carcinoma, Small Cell, Bulbo-Spinal Atrophy, X-Linked, Small Cell Lung Carcinoma

NCT03300505 2025-05-13

ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer

Phase 1 Terminated

9 enrolled 14 charts

Prostatic Neoplasms

NCT05177770 2025-05-08

Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 2 Terminated

16 enrolled 10 charts

Neoplasms, Prostatic Neoplasms

NCT04607135 2025-05-06

ARFI Imaging for Targeted Prostate Biopsy

Phase NA Terminated

34 enrolled 18 charts

Prostatic Neoplasms

NCT01341288 2025-05-02

EUCLIDIAN

Phase 1 Terminated

Prostatic Neoplasms

NCT01313559 2025-04-30

Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer

Phase 2 Terminated

6 enrolled 10 charts

Prostatic Neoplasms